Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients

被引：3
|
作者：
He, Rong [1 ]
Chiou, Jonathan [2 ]
Chiou, Allison [3 ]
Chen, Dong [1 ]
Chen, Constance P. [4 ]
Spethman, Caroline [5 ]
Bessonen, Kurt R. [1 ]
Oliveira, Jennifer L. [1 ]
Nguyen, Phuong L. [1 ]
Reichard, Kaaren K. [1 ]
Hoyer, James D. [1 ]
Althoff, Simon D. [1 ]
Roh, Dana J. [1 ]
Miller, Mechelle A. [1 ]
Yuan, Ji [1 ]
Olteanu, Horatiu [1 ]
Begna, Kebede [6 ]
Tefferi, Ayalew [6 ]
Alkhateeb, Hassan [6 ]
Patnaik, Mrinal M. [6 ]
Litzow, Mark R. [6 ]
Al-Kali, Aref [6 ]
Viswanatha, David S. [1 ]
机构：
[1] Mayo Clin, Coll Med, Div Hematopathol, Rochester, MN 55905 USA
[2] Dartmouth Coll, Hanover, NH USA
[3] Wellesley Coll, Wellesley, MA USA
[4] Univ Notre Dame, Coll Sci, Notre Dame, IN 46556 USA
[5] Univ Nebraska, Sch Med, Omaha, NE 68198 USA
[6] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA
来源：
BLOOD CANCER JOURNAL | 2022年 / 12卷 / 01期
关键词：
CLONAL HEMATOPOIESIS; MUTATIONS; MDS; RISK;
D O I：
10.1038/s41408-022-00612-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Prognostic value study of lung cancer molecular markers
    Garcia Lujan, Ricardo
    Conde Gallego, Esther
    Lopez Rios, Fernando
    Luis Martin De Nicolas, Jose
    Sanchez Cespedes, Montserrat
    Garcia Quero, Cristina
    Lopez Encuentra, Angel
    MEDICINA CLINICA, 2009, 132 (14): : 529 - 536
  • [42] The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group
    Papageorgiou, Sotirios G.
    Vasilatou, Diamantina
    Kontos, Christos K.
    Kotsianidis, Ioannis
    Symeonidis, Argiris
    Galanopoulos, Athanasios G.
    Hatzimichael, Eleftheria
    Megalakaki, Aekaterini
    Poulakidas, Elias
    Diamantopoulos, Panagiotis
    Vassilakopoulos, Theodoros P.
    Zikos, Panagiotis
    Papadaki, Helen
    Mparmparousi, Despoina
    Bouronikou, Eleni
    Panayiotidis, Panayiotis
    Viniou, Nora-Athina
    Pappa, Vassiliki
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 895 - 901
  • [43] The value of prognostic markers for pediatric trauma patients
    Durak, Cansu
    Sahin, Ebru Guney
    Can, Yasar Yusuf
    Sarisaltik, Alican
    Guvenc, Kubra Boydag
    WORLD JOURNAL OF EMERGENCY MEDICINE, 2023, 14 (06) : 448 - 453
  • [44] MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes
    Choi, Ji-Seon
    Nam, Myung-Hyun
    Yoon, Soo-Young
    Kang, Seong-Ho
    LEUKEMIA RESEARCH, 2015, 39 (07) : 763 - 768
  • [45] Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
    Sauta, Elisabetta
    Robin, Marie
    Bersanelli, Matteo
    Travaglino, Erica
    Meggendorfer, Manja
    Zhao, Lin-Pierre
    Caballero Berrocal, Juan Carlos
    Sala, Claudia
    Maggioni, Giulia
    Bernardi, Massimo
    Di Grazia, Carmen
    Vago, Luca
    Rivoli, Giulia
    Borin, Lorenza
    D'Amico, Saverio
    Tentori, Cristina Astrid
    Ubezio, Marta
    Campagna, Alessia
    Russo, Antonio
    Mannina, Daniele
    Lanino, Luca
    Chiusolo, Patrizia
    Giaccone, Luisa
    Voso, Maria Teresa
    Riva, Marta
    Oliva, Esther Natalie
    Zampini, Matteo
    Riva, Elena
    Nibourel, Olivier
    Bicchieri, Marilena
    Bolli, Niccolo'
    Rambaldi, Alessandro
    Passamonti, Francesco
    Savevski, Victor
    Santoro, Armando
    Germing, Ulrich
    Kordasti, Shahram
    Santini, Valeria
    Diez-Campelo, Maria
    Sanz, Guillermo
    Sole, Francesc
    Kern, Wolfgang
    Platzbecker, Uwe
    Ades, Lionel
    Fenaux, Pierre
    Haferlach, Torsten
    Castellani, Gastone
    Della Porta, Matteo Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) : 2827 - +
  • [46] Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes
    Jiang, Lingxu
    Luo, Yingwan
    Zhu, Shuanghong
    Wang, Lu
    Ma, Liya
    Zhang, Hua
    Shen, Chuying
    Yang, Wenli
    Ren, Yanling
    Zhou, Xinping
    Mei, Chen
    Ye, Li
    Xu, Weilai
    Yang, Haiyang
    Lu, Chenxi
    Jin, Jie
    Tong, Hongyan
    CANCER SCIENCE, 2020, 111 (02) : 580 - 591
  • [47] The Impact of Cytomorphology, Cytogenetics, Molecular Genetics, and Immunophenotyping in a Comprehensive Diagnostic Workup of Myelodysplastic Syndromes
    Bacher, Ulrike
    Haferlach, Torsten
    Kern, Wolfgang
    Weiss, Tamara
    Schnittger, Susanne
    Haferlach, Claudia
    CANCER, 2009, 115 (19) : 4524 - 4532
  • [48] Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients
    Schroeder, T.
    Ruf, L.
    Bernhardt, A.
    Hildebrandt, B.
    Aivado, M.
    Aul, C.
    Gattermann, N.
    Haas, R.
    Germing, U.
    ANNALS OF ONCOLOGY, 2010, 21 (11) : 2267 - 2271
  • [49] Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes
    Noesslinger, T.
    Tuechler, H.
    Germing, U.
    Sperr, W. R.
    Krieger, O.
    Haase, D.
    Luebbert, M.
    Stauder, R.
    Giagounidis, A.
    Valent, P.
    Pfeilstoecker, M.
    ANNALS OF ONCOLOGY, 2010, 21 (01) : 120 - 125
  • [50] Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis
    Wang, Huifang
    Zhang, Nanchen
    Wu, Xia
    Zheng, Xue
    Ling, Yantao
    Gong, Yuping
    ANNALS OF HEMATOLOGY, 2019, 98 (12) : 2629 - 2639
12345